In June 2019 the India National Anti-Doping Agency (INADA) has reported an anti-doping rule violation against the bodybuilder Vaibhav Ganpatrao Markantewar after his sample tested positive for the prohibited substances Clenbuterol, Furosemide, Growth Hormone Releasing Peptide (GHRP), Mesterolone and Stanozolol.
After notification a provisional suspension was ordered. The Athlete filed a statement in his defence and he was heard for the Anti-Doping Disciplinary Panel of India (ADDPI). The Athlete denied the intentional use and explained that he had used these substances on advise of his personal coach.
The Panel finds that the test result showed the presence of the prohibited substances in the Athlete’s sample and accordingly that he committed an anti-doping rule violation.
The Panel concludes that the Athlete failed to establish that the violation was not intentional and decides therefore on 16 December 2019 to impose a 4 year period of ineligibility on the Athlete starting on the date of the provisional suspension, i.e. on 7 June 2019.